Sign in

Peter Loftus

@loftus.bsky.social
691 followers 91 following 7 posts

Reporter covering drug companies, medical-device companies for The Wall Street Journal. Author of The Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World

PostsRepliesMedia
Peter Loftus @loftus.bsky.social · 28/01/2025
Sign of the times: telehealth firm's ad for weight-loss drugs to run during Super Bowl (by my colleague Katie Deighton): www.wsj.com/articles/him...
wsj.com
Hims & Hers to Advertise Weight-Loss Shots at the Super Bowl
Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced injectables.
140
Reposted by Peter Loftus
The Wall Street Journal @wsj.com · 17/01/2025
Breaking: Ozempic and Wegovy are among 15 drugs up for a new round of price negotiations by Medicare
wsj.com
Ozempic Among the Next Drugs Up for Medicare Price Negotiations
List of drugs account for $41 billion in annual Medicare spending, the Biden administration said.
23210
Reposted by Peter Loftus
The Wall Street Journal @wsj.com · 13/01/2025
JPMorgan is hosting its first major healthcare gathering since the death of UnitedHealthcare’s CEO Brian Thompson and security around industry leaders will be heavy
wsj.com
JPMorgan Hosts First Major Healthcare Gathering Since Death of UnitedHealthcare’s CEO
Industry leaders from more than 500 companies scheduled to give investor presentations will see heightened security surrounding the conference and related events. Many will have personal bodyguards.
8145
Peter Loftus @loftus.bsky.social · 13/01/2025
Got news tips for The Wall Street Journal? Here are some secure ways to send tips or documents, anonymously or otherwise: www.wsj.com/tips
wsj.com
WSJ Tips
020
Peter Loftus @loftus.bsky.social · 26/11/2024
Will Medicare and Medicaid broadly cover anti-obesity meds like Wegovy? Outgoing Biden administration proposes it, up to incoming Trump admin to keep or scrap it. W/ @lizessleywhyte.bsky.social : www.wsj.com/health/healt...
wsj.com
White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs
More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the proposal.
381
Peter Loftus @loftus.bsky.social · 19/11/2024
The tried-and-true pharma marketing methods--TV ads, sales reps, etc.--only go so far when it comes to weight loss drugs. That's why Lilly and Novo are sending reps to employers, to get more of them to cover the drugs. It's not an easy sell, because of the high cost: www.wsj.com/health/pharm...
wsj.com
Makers of Weight-Loss Drugs Want Your Employer to Pay for Them
Eli Lilly, Novo Nordisk reps get facetime with employers in hopes they’ll cover their drugs
041
Peter Loftus @loftus.bsky.social · 21/10/2024
I wrote about the increasing use of an unusual treatment for difficult depression, J&J's Spravato, a cousin of ketamine: www.wsj.com/health/healt...
wsj.com
020
Peter Loftus @loftus.bsky.social · 08/02/2024
Novo Nordisk's planned purchase of Catalent's manufacturing plants underscores the mismatch between demand and supply of popular new weight loss drugs: www.wsj.com/business/dea...
010